<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rossi M</submitter><funding>Intramural NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>2429-34</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2808702</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>19(9)</volume><pubmed_abstract>Cancer cells evade death by over-producing specific proteins that inhibit apoptosis. One such group of proteins is the Bcl-2 family, of which Bcl-x(L) is an important member. This protein binds and inhibits BAK, another protein that promotes apoptosis. While the development of chemical inhibitors that block Bcl-x(L)-BAK association have been the focus of intense research efforts, we demonstrate in this manuscript an alternative strategy to downregulate Bcl-x(L). We have identified a small molecule (Bang52) that induces apoptosis in a lymphoblast-derived cell line by lowering levels of Bcl-x(L). Since Bang52 bears no resemblance to any chemical binder of Bcl-x(L) we believe that degradation of the protein is stimulated by a new type of pathway. These findings highlight a novel approach to the development of small molecules that promote apoptosis.</pubmed_abstract><journal>Bioorganic &amp; medicinal chemistry letters</journal><pubmed_title>Induction of apoptosis promoted by Bang52; a small molecule that downregulates Bcl-x(L).</pubmed_title><pmcid>PMC2808702</pmcid><funding_grant_id>P30 CA021765</funding_grant_id><funding_grant_id>CA6320</funding_grant_id><funding_grant_id>Z01 DK031123-04</funding_grant_id><funding_grant_id>CA21765</funding_grant_id><funding_grant_id>Z01 DK031123-03</funding_grant_id><funding_grant_id>ZIA DK031123-05</funding_grant_id><pubmed_authors>Zambetti GP</pubmed_authors><pubmed_authors>Mazur S</pubmed_authors><pubmed_authors>Bang JK</pubmed_authors><pubmed_authors>Rossi M</pubmed_authors><pubmed_authors>Appella DH</pubmed_authors><pubmed_authors>Iera JA</pubmed_authors><pubmed_authors>Phillips DC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Induction of apoptosis promoted by Bang52; a small molecule that downregulates Bcl-x(L).</name><description>Cancer cells evade death by over-producing specific proteins that inhibit apoptosis. One such group of proteins is the Bcl-2 family, of which Bcl-x(L) is an important member. This protein binds and inhibits BAK, another protein that promotes apoptosis. While the development of chemical inhibitors that block Bcl-x(L)-BAK association have been the focus of intense research efforts, we demonstrate in this manuscript an alternative strategy to downregulate Bcl-x(L). We have identified a small molecule (Bang52) that induces apoptosis in a lymphoblast-derived cell line by lowering levels of Bcl-x(L). Since Bang52 bears no resemblance to any chemical binder of Bcl-x(L) we believe that degradation of the protein is stimulated by a new type of pathway. These findings highlight a novel approach to the development of small molecules that promote apoptosis.</description><dates><release>2009-01-01T00:00:00Z</release><publication>2009 May</publication><modification>2020-10-31T09:41:35Z</modification><creation>2019-03-27T00:28:03Z</creation></dates><accession>S-EPMC2808702</accession><cross_references><pubmed>19349174</pubmed><doi>10.1016/j.bmcl.2009.03.067</doi></cross_references></HashMap>